Global Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Iovance Biotherapeutics

Market Cap: US$767.1m

A commercial-stage biopharmaceutical company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States.

Dogwood Therapeutics

Market Cap: US$9.8m

A development-stage biotechnology company, focuses on the development of medicine to treat pain and fatigue-related disorders.

Bolt Biotherapeutics

Market Cap: US$11.1m

A clinical-stage biopharmaceutical company, engages in the development of immunotherapies for the treatment of cancer.

PeptiDream

Market Cap: JP¥208.0b

A biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics.

Athira Pharma

Market Cap: US$16.1m

Athira Pharma, Inc., clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation.

Candel Therapeutics

Market Cap: US$298.1m

A clinical stage biopharmaceutical company, develops immunotherapies for the cancer patients.

RAMM Pharma

Market Cap: CA$1.8m

Engages in the pharmaceutical and medical product business in Uruguay, Italy, and Poland.

Synairgen

Market Cap: US$220.5k

Synairgen plc discovers and develops drugs for respiratory diseases.

Novavax

Market Cap: US$1.4b

A biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally.

Ardelyx

Market Cap: US$1.5b

Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.

Chengdu Olymvax Biopharmaceuticals

Market Cap: CN¥10.7b

Engages in the research and development, production, and sales of vaccines for human use.

Healios K.K

Market Cap: JP¥66.1b

Engages in the research and development, manufacture, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States.

Daewon Pharmaceutical

Market Cap: ₩281.4b

A pharmaceutical company, manufactures and sells medicines and medical supplies in South Korea.

Delta-Fly Pharma

Market Cap: JP¥5.3b

Develops anticancer drugs.

Abnova (Taiwan)

Market Cap: NT$1.6b

Manufactures and sells various recombinant proteins and antibodies.

KYORIN Pharmaceutical

Market Cap: JP¥87.3b

Through its subsidiaries, researches and develops, manufactures, and sells ethical and generic drugs in Japan and internationally.

AbClon

Market Cap: ₩300.9b

Engages in the research and development of antibody drugs in South Korea and Sweden.

Shanghai RAAS Blood Products

Market Cap: CN¥44.2b

Engages in the manufacture and sale of blood products in China.

iNtRON Biotechnology

Market Cap: ₩123.0b

Engages in the development of novel drugs in South Korea.

Shanghai Kehua Bio-EngineeringLtd

Market Cap: CN¥3.2b

Researches and develops, produces, and sells in vitro diagnostic reagents, medical testing equipment and other products in China and internationally.

Hanshang Group

Market Cap: CN¥2.7b

Primarily engages in the retail business.

Hubei Hongyuan Pharmaceutical Technology

Market Cap: CN¥5.6b

Engages in the production and sale of pharmaceutical products in China and internationally.

Guizhou Yibai Pharmaceutical

Market Cap: CN¥3.2b

Researches, develops, produces, and sells pharmaceutical products in China.

Daehan NupharmLtd

Market Cap: ₩96.1b

Manufactures and sells pharmaceuticals and veterinary products in South Korea and internationally.

Thalys Medical Technology Group

Market Cap: CN¥5.1b

Provides intensive operation services of medical inspection in China.

Prince Pharmaceutical

Market Cap: NT$1.3b

Manufactures and sells vitamin B1 active pharmaceutical ingredients (APIs) in Taiwan, Japan, Korea, and internationally.

ChengDa Pharmaceuticals

Market Cap: CN¥4.5b

Engages in the research and development, production, and sale of pharmaceutical intermediates, chemical ingredients, and food and feed additives in China and internationally.

Kangmei Pharmaceutical

Market Cap: CN¥28.1b

Produces and sells Chinese herbal medicines in China.

Kolon TissueGene

Market Cap: ₩4.1t

Develops cell therapies for orthopedic diseases and other unmet medical needs.

Jiangsu Sinopep-Allsino Biopharmaceutical

Market Cap: CN¥12.9b

A biomedical company, engages in the research and development, production, sale, and technical service of peptides and small molecule drugs in China.

Tus-Pharmaceutical Group

Market Cap: CN¥2.8b

Manufactures and sells Chinese patent medicines, chemical medicines, and health foods in China.

Botanix Pharmaceuticals

Market Cap: AU$294.2m

Operates as a commercial dermatology company in Australia and the United States.

Actinogen Medical

Market Cap: AU$98.4m

A biotechnology company, develops therapies for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol in Australia.

PharmGen Science

Market Cap: ₩83.1b

Engages in the research and development, production, and sale of pharmaceutical products in South Korea.

SSY Group

Market Cap: HK$8.7b

An investment holding company, researches, develops, manufactures, trades in, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally.

Akeso

Market Cap: HK$125.0b

A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of antibody drugs worldwide.